Charles River Laboratories International
CRL55
$198.61arrow_drop_up2.20%$4.28
S&P500
CRL55
$198.61
arrow_drop_up2.20%| Key Stats | |
|---|---|
| Open | $195.06 |
| Prev. Close | $194.32 |
| EPS | 8.36 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 194.89 | 198.94 |
| 52 Week Range | 161.64 | 275.00 |
| Ratios | |
|---|---|
| EPS | 8.36 |
| Fundamentals | |
|---|---|
| Payout Ratio | - |
| Industry average yield | 2.96% |
| Last Dividend pay date | - |
| Dividend per share | - |
| Dividend yield forecast | - |
Stock Analysis
Technicals
Summarizing what the indicators are suggesting.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Analyst rating
An aggregate view of professional's ratings.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Stock Performance
CRL-
US Healthcare Sector-
US Market-
check_circle
CRL / Market
CRL exceeded the US Market which returned -0.09% over the last twenty four hours.check_circle
CRL / Healthcare Sector
CRL exceeded the US Healthcare sector which returned 0.72% over the last twenty four hours.Charles River Laboratories International (CRL) Statistics
Keep an eye on Charles River Laboratories International
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
How has Charles River Laboratories International (CRL) stock's performance compared to its sector and the market over the past year?
Over the past year, Charles River Laboratories International (CRL) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 22.23%, Charles River Laboratories International has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 61.01%, it has fallen short of the market average. This comparison highlights Charles River Laboratories International 's performance relative to both its sector and the overall market over the last year.
help
What is the PE ratio of Charles River Laboratories International (CRL) stock?
The PE (Price to Earnings) ratio of Charles River Laboratories International (CRL) is currently 23.76. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help
What is the EPS of Charles River Laboratories International (CRL) stock?
The Earnings Per Share (EPS) for Charles River Laboratories International (CRL), calculated on a diluted basis, is $8.36. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help
What is the operating margin of Charles River Laboratories International (CRL) stock?
The operating margin for Charles River Laboratories International (CRL) is 16.6%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help
What is the EBITDA of Charles River Laboratories International (CRL) stock?
The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Charles River Laboratories International (CRL) is $1.01B. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help
How much debt does Charles River Laboratories International (CRL) have?
Charles River Laboratories International (CRL) has a total debt of $2.84B. The net debt, which accounts for cash and cash equivalents against the total debt, is $2.66B.